Senator seeks clarification from FDA regarding safety concerns of COVID vaccines for children.

The U.S.⁣ Agencies Urged to Disclose ⁣Seizure Risks in Children from COVID-19 Vaccines

A U.S.⁣ senator is calling ‍for transparency ⁢from the ‍U.S.​ Food and Drug⁤ Administration (FDA) and U.S. Centers for Disease Control and Prevention (CDC) regarding their⁤ knowledge of the potential link between COVID-19 vaccines ‌and seizures in children. Sen.⁢ Ron Johnson (R-Wis.) ⁢insists that these agencies should reveal when they first​ became aware of this information, after both organizations declined to disclose it to The Epoch ‌Times.

In a preprint ‌paper published on Oct. 15, FDA researchers‌ revealed⁣ the detection of‌ a safety signal ⁢ for seizures ⁣and ⁤convulsions in children aged ⁤2 to 5 following⁢ COVID-19 ⁣vaccination.

Related Story

• EXCLUSIVE: FDA Refuses⁤ to Provide COVID-19 ⁤Vaccine Safety ‍Data to ⁣US Senator

  9/7/2023

The ‍FDA researchers’ paper only included data up until April. However, about a month ⁣before its release, the FDA authorized COVID-19 shots from Moderna and Pfizer for children as young as 6⁢ months old. The CDC then⁤ recommended these shots for almost all Americans, despite limited supporting ‍data. Notably, neither‌ agency mentioned the potential‌ risk of ‍seizures and convulsions.

Sen. Johnson directly ⁤questioned ⁣the FDA and CDC heads ⁣on Oct. 25, asking when they first became aware of the findings‌ from the FDA-funded study published on Oct. 15, 2023. He demanded the names and ‍titles of the individuals initially informed about the ⁢study’s‍ findings.

The​ FDA ⁣researchers ‌emphasized the​ need for further investigation of ⁢the seizure signal ⁢”in⁣ a‌ robust epidemiological study.” Sen. ⁤Johnson⁤ inquired about the FDA’s progress in conducting‌ such⁤ a ‍study and any⁣ actions taken by the FDA and CDC in response to the signal.

Sen. Johnson⁤ believes​ that this new information​ could challenge the ⁤prevailing notion ‌that the ‍benefits of the vaccines outweigh the ‌risks. While the‍ CDC and FDA maintain that this is true for most ⁣Americans, other ​countries ⁣like Denmark have limited ‌COVID-19 vaccination to specific groups due to ⁢declining vaccine⁢ effectiveness and‌ high⁣ levels of prior infection in the population.

The FDA has​ refused to ‍disclose when its ⁤officials first became‌ aware of the ‍seizure signal.

“The FDA is‌ confident in the safety,⁤ effectiveness, and quality of the COVID-19 vaccines. ​The available data continue to demonstrate that the benefits of these vaccines outweigh their ⁣risks,” ⁢stated an FDA‍ spokeswoman in‌ an email to The Epoch‌ Times, sidestepping ⁢the question about the signal’s initial detection.⁤ The CDC ⁤did not respond to inquiries regarding‍ when they were first⁤ informed of the ‍signal. Pfizer and‌ Moderna have also remained unresponsive.

Transparency advocates argue ⁢that​ the lack of openness undermines⁢ public trust ⁢in these health agencies. Barbara ‌Loe Fisher, founder ⁣and co-president of the National Vaccine Information Center, expressed ⁢her concerns, stating, “Trust is lost in public‌ health policy recommendations when health ‌officials ​either refuse or are slow to make information available that can help people weigh the⁣ risks for themselves when ⁢considering their own current health ⁣and medical history.”

Other Concerns

Sen. Johnson,‌ as ‍the ranking member‌ of the Senate‌ Homeland Security and Governmental Affairs Permanent Subcommittee on⁤ Investigations, has been particularly focused on COVID-19 vaccine safety.⁣ He has persistently‌ requested information from federal officials that has either⁤ been withheld or reported in the media.

For example,‌ Sen. Johnson asked the FDA for ⁢the results of data mining ​ conducted on adverse event reports. The ‌Epoch Times obtained similar ⁤results ​from their own mining, which revealed hundreds of signals‍ for the Pfizer and Moderna shots.

In September, the FDA refused to provide Sen. ‍Johnson with the requested data, citing ⁣ongoing litigation. The FDA and CDC have also withheld information on post-vaccination deaths, COVID-19 ⁤cases among the ‍vaccinated, subclinical heart inflammation studies,‍ and early warnings about myocarditis after Pfizer‌ vaccination.

Sen. Johnson has sent ⁣60 letters ​to federal agencies in his pursuit of⁣ answers but has⁢ received⁣ minimal responses. He emphasized that “federal​ health agencies must be transparent and provide all the information ​they have‌ so that patients can ‍benefit from informed⁢ consent. ​To date, they have failed to do so,”⁤ and demanded that they disclose ⁣their ⁤knowledge.

Sen. Johnson concluded his message to the FDA, CDC, ⁣and U.S. Department of Health and Human Services leaders by stating that they have a duty to provide complete and ‍transparent data on the safety and effectiveness of COVID-19 vaccines. He expressed his disappointment in their ⁢lack of transparency, ​stating that their refusal to ‍do so is ‌”completely ‍unacceptable.”

“The fact ‍that the vast majority of my questions and information requests remain unanswered or outstanding,” he wrote, “only heightens my level of suspicion.”

The FDA⁢ researchers in their preprint paper.

Regarding adverse reactions, long-term⁢ effects, and risk assessments associated ‌with COVID-19 vaccines. In a ​letter sent to Dr. Rochelle⁢ Walensky, Director of the CDC, and Dr. Janet Woodcock, Acting Commissioner of the FDA, Sen. Johnson expressed his concerns and demanded transparency in disclosing information related to the potential⁢ link ‍between COVID-19 vaccines and seizures in children.

The call for transparency stems⁣ from a preprint paper published ⁢on‍ October 15 by ⁣FDA researchers, which revealed a ⁤safety signal for⁣ seizures⁤ and convulsions in children aged ​2 to 5‌ following COVID-19 vaccination. While ‌the paper only ‍included data up until April, it is alarming that ‌both the FDA and CDC authorized and recommended‌ COVID-19 ⁤shots for children as young as 6 months without mentioning the potential risks ⁣associated with seizures and⁤ convulsions.

Sen. Johnson directly questioned the heads ⁣of the FDA and CDC, seeking information on when they ⁤first ⁣became aware of the findings from the FDA-funded study published on October 15, 2023. He⁤ demanded⁤ the names and titles of the ⁤individuals who were initially informed ​about the study’s findings. Additionally, Sen. Johnson ‍inquired about ​the progress of‌ the​ FDA in conducting a robust epidemiological study to further investigate the seizure⁢ signal, as mentioned by